feed,title,long_url,short_url
Benzinga,FDA Approves Regeneron/Sanofi's Libtayo For Front-Line Lung Cancer,https://benzinga.com/general/biotech/21/02/19792509/fda-approves-regeneronsanofis-libtayo-for-front-line-lung-cancer,
